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Abstract
The expression of p63 (TP63/p51) occurs in the basal cells of stratified epithelia and is strongly enhanced at the early
stages of squamous cell carcinomas (SCCs) of the head and neck, skin, cervix, and others. We analyzed a promoter/
enhancer region (2kΔN) that drives the predominant expression ofΔNp63 for sensitivity to Smad signaling pathways.
Reporter assays in HepG2 cells showed amoderate activation of 2kΔN by Smad2 and IκB kinase α (IKKα), partners of
the newly identified keratinocyte-specific transforming growth factor β (TGF-β) signaling, but not by other Smad
molecules. In A431 cells, 2kΔN was activated by Smad2 and IKKα, for which a Smad binding element (SMD2) at
−204 was essential. Binding of Smad2 to the chromosomal SMD2 site was detectable. The association of Smad2
with IKKα was evident in the nucleus of A431, accounting for the enhancement of ΔNp63 expression by TGF-β.
Moreover, both ΔNp63 and IKKα were necessary to maintain the noninvasive phenotype of this cell line. FaDu, an
invasive, Smad4-deficient SCC, also allowed 2kΔN transactivation by transfected Smad2 in the presence of endog-
enous IKKα. Reflecting the lack of chromosomal SMD2-Smad2 association and the absence of nuclear IKKα, how-
ever, endogenous ΔNp63 was not controlled by TGF-β or IKKα in FaDu. SCC tissue arrays showed nuclear
accumulation of IKKα and p63 intensification in well-differentiated noninvasive lesions. This study indicates that
p63 is a target gene of the proposed keratinocyte-specific TGF-β signal pathway for suppression of the malignant
conversion of SCC.
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Introduction
Unlike p53, which is ubiquitously expressed to exert the tumor-
suppressing function, p63 (TP63, p51) [1,2] is required for the devel-
opment of stratified epithelia including the skin and oral tissues [3,4].
A high level of expression of p63 occurs not only in keratinocyte stem
cells of normal stratified epithelia [5,6] but also in squamous cell car-
cinomas (SCCs) of head and neck, skin, and cervix as well as in carci-
nomas of urothelia and others [7–9]. After the intensification at the
lower-grade carcinomas, however, p63 expression diminishes during
the malignant progression [10–13]. Although various genes induced
by p63 have been reported [14–19], it remains obscure how p63 gene
expression is enhanced at the limited stages of the specific lineages in
tissue development and cancer progression.
The human p63 locus has two separate transcriptional initiation sites
to produce transactivator protein TAp63 and N-terminally truncated
protein ΔNp63. Because ΔNp63 isoform expression is significantly
more predominant than TAp63 in normal keratinocytes and SCCs
[2,8,15], the ΔNp63 promoter immediately upstream of exon 3′ is
thought to control the level of ΔNp63 and overall functions of p63.
An earlier report showed that ΔNp63 of zebrafish, the only p63 tran-
script of this species, is induced by bone morphogenetic protein 2
(BMP2) through Smad binding elements (SBEs) in the promoter/
enhancer region [20].
In addition to the canonical Co-Smad/R-Smad signaling pathways of
TGF-β and BMP, varied modes of cross-talk between the Smad systems
and other cellular signaling mechanisms have been studied [21,22]. In-
terestingly, a keratinocyte-specific TGF-β signaling pathway has been
recently identified, in which IκB kinaseα (IKKα) instead of Smad4 acts
like Co-Smad to interact with Smad2/3 (R-Smad) for transcriptional
activation of the target genes [23,24]. Apart from the protein kinase
activity required for the NF-κB pathway activation in the cytosol,
IKKα needs to translocate to the nucleus for this function. As earlier
studies showed, IKKα-deficient mice manifest severe defects in the
skin and limbs because of the blockage of keratinocyte differentia-
tion [25,26].
The Smad2/3-IKKα pathway is activated in noninvasive well-
differentiated (grade 1) SCCs but seems switched off on the malignant
conversion into invasive (grade 3) SCCs [27]. These processes are ob-
served in conjunction with nuclear translocation of IKKα in grade 1
SCCs and its cytosolic sequestration in grade 3 SCC. Intriguingly, a
line of evidence indicated that both TAp63 and ΔNp63 activate tran-
scription of the IKKα gene (CHUK, also termed IKBKA, IKK-alpha,
IKK1, etc) in humans [18,28,29].
Because the p63 expression pattern is well conserved over a wide range
of species [20,30], we investigated how p63 is influenced by the human
Smad signaling systems. Our results indicate that the ΔNp63 promoter
is activated by the keratinocyte-specific TGF-β signaling mechanism
with Smad2 and IKKα. Functional interactions between IKKα and
p63 in SCC progression are discussed.
Materials and Methods
Cell Culture
HepG2 and A431 cells were obtained from the Japan Health Sci-
ences Foundation. C2C12 and FaDu were from the American Type
Culture Collection. HepG2, A431, C2C12 cells were propagated in
Dulbecco modified minimum essential medium (D-MEM) with 10%
fetal bovine serum (FBS). FaDu cells were maintained in MEM supple-
mented with sodium pyruvate, nonessential amino acids, glutamine, and
10% FBS.
Luciferase Reporter Assay
Chromosomal DNA obtained from a healthy donor (Y.T.) was am-
plified by polymerase chain reaction (PCR) to obtain 2kΔN (−1848 to
+152; Figure 1) and 2kTA (−1911 to +89, in which +1 was tentatively
placed at the reported 5′ end of TAp63α complementary DNA
[cDNA], NM_003722). The DNA segments were cloned into
pGL3basic (Promega, Madison, WI) at the Xho I site and sequenced.
In vitromutagenesis was carried out with the GeneTailor Site-directed
Mutagenesis System (Invitrogen, Carlsbad, CA). The Smad1 expression
vector pcDNA3-Flag(N)-Smad1 and the Id1 promoter linked to the
luciferase gene (BRE-luc) were from Dr Kohei Miyazono, University
of Tokyo. Smad2 was described [31]. The Smad3, Smad4, and Smad5
cDNAwere isolated from aHeLa cell cDNA library (RIKEN, Tsukuba,
Japan), cloned into pRc/CMV (Invitrogen), and sequenced. An IKKα
expression vector (CHUK,NM_001278.3), pCMV6-XL5-CHUKwas
purchased from OriGene Technologies, Rockville, MD. Plasmid DNA
transfectionwas carried out withAttractene (Qiagen,Hilden, Germany)
for HepG2, C2C12, and FaDu and with Superfect (Qiagen) for A431.
Eighteen hours after transfection, cells were starved in 0.1% serum
for 6 hours and were further incubated for 24 hours with or without
TGF-β1 (R&D Systems, Minneapolis, MN) at 10 ng/ml, a concen-
tration relevant to experiments with epithelial cells [32]. We used
the Luciferase Assay Kit (Promega) for FaDu and A431 and the
Steady-Glo Luciferase Assay System (Promega) for HepG2 and
C2C12 cells.
Figure 1. SBE-like sequences found in thepromoter/enhancer region
ofΔNp63. (A) Theproximal promoter region of humanΔNp63 is sche-
matically shown. The 5′ end of the reported ΔNp63α cDNA data
(NM_001114980) is marked by a filled triangle. Nucleotide stretches
matching the consensus sequencesof initiators, 5′-(C/T)(C/T)AN(A/T)
(C/T)(C/T)-3′, andTATAbox, 5′-TATA(T/A)A(T/A)(A/G)-3′, are underlined.
Provisional initiation site (position+1) ofΔNp63 ismarked by a rect-
angular arrow. Filled and open arrows represent the SBE motif
5′-AGAC-3′, and its complementary sequence 5′-GTCT-3′, respectively.
Relative positions are shown for SMD1 (a complete palindrome includ-
ing 5′-TCT-AGA-3′, SMD2 (a tandem repeat of 5′-GTCT-3′), andSMD-HS
(a repeat of 5′-AGAC-3′ interruptedby 20nucleotides).Mutated nucleo-
tides in SMD1m, SMD2m and SMD-HS2m are in lower case. (B) The
zebrafish (Danio rerio) ΔNp63 promoter/enhancer region with func-
tional SBE sites are shown as described by Bakkers et al. [20].
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Gene Silencing
SiLentfect (Bio-Rad, Hercules, CA) was used for small interfering
RNA (siRNA) transfection. FaDu cells were transfected in MEM with
10% FBS. A431 cells were incubated with Opti-MEM serum-free me-
dium (Invitrogen) during the siRNA transfection (18 hours) and refed
with D-MEM with 10% FBS. A pair of siRNA duplex targeting p63
(p63si) was designed by us [15] and synthesized by Takara Bio (Otsu,
Japan). Control siRNA (Csi) and IKKα-targeting siRNA (IKKαsi)
were purchased from Ambion (Austin, TX; AM4611) and Dharmacon
(Lafayette, CO; M-003473S), respectively.
Western Blot Analysis
Whole-cell lysates were subjected toWestern blot analysis as described
[14].We purchased anti-p63 (4A4, mouse), anti-IKKα (sc-7218, rabbit),
anti-Smad2 antibody (sc-101153, mouse), and anti-Smad4 (sc-7966,
mouse) antibodies from Santa Cruz Biotechnology (Santa Cruz, CA).
A rabbit anti-Flag antibody (PM020;MBL International,Woburn,MA)
was used for Flag-Smad2 immunoprecipitation. Anti-HSP90 (ab1429,
mouse) and anti-p84 (ab487, mouse) antibodies were from Abcam
(Cambridge, UK). An anti–phospho-Smad2 (Ser465/467, #3101)
antibody was from Cell Signaling Technology (Beverly, MA). Alkaline
phosphatase (AP)–conjugated secondary antibodies (Cell Signaling
Technology) were applied. Size markers (Biotinylated SDS-PAGE
Standards; Bio-Rad) were detected with an AP-conjugated antibiotin
immunoglobulin G (IgG; Cell Signaling Technology). Chemilumines-
cence (CDP-Star Reagent; New England Biolabs, Ipswich, MA) was
captured with a camera luminometer (ECL Mini-camera; Amersham
Pharmacia Biotech, Uppsala, Sweden), in which luminescence images
appear white on the black background. Scanned digital images were pro-
cessed by Photoshop (Adobe Systems, San Jose, CA) without a modifica-
tion of the band intensity. Proteins were semiquantified with an imaging
program, ImageJ (National Institutes of Health, Bethesda, MD).
Chromatin Immunoprecipitation
Weused chromatin immunoprecipitation (ChIP) ITExpression Enzy-
matic, ChIP IT Control Kit (Active Motif, Carlsbad, CA), and an anti-
Smad2 antibody (51-1300; Zymed Laboratories, South San Francisco,
CA). A431 and FaDu cells required 100 strokes of homogenization in
Dounce homogenizer (Wheaton, DuPage County, IL) for efficient
nuclear release. A SMD2-containing segment was amplified by PCR
with primers 5′-ATCATTCTTGAAACCCCAAATCTA-3′ (−411 to
−388) and 5′-CCAGGAGACAGACAGGTAAAACTT-3′ (−215 to
−192). A segment upstream of TAp63 was also amplified with 5′-
TACATGTGCATGTGTTTGAGGTAG-3′ and 5′-TAGAGCTGCT-
TAGGGAAGTTTTGT-3′.
Reverse Transcription–Polymerase Chain Reaction
RNA isolated with RNAwiz (Ambion) was further cleaned up using
the RNeasy MinElute Cleanup Kit (Qiagen). Reverse transcription–
polymerase chain reaction (RT-PCR; 30 μl) contained the SuperScript
One-Step RT-PCR reagent with Platinum Taq (Invitrogen), RNA
(0.6 μg), and the primers described previously [14,15].
Immunofluorescence Staining
Cells were cultured on the Lab-Tek chamber slides (Nunc, Roskilde,
Denmark). Cancer tissues were obtained from patients with informed
consent at Kanagawa Dental College Hospital (Yokosuka, Japan). SCC
tissue array slides, BC34011, and OR802 were from US Biomax
(Rockville, MD). Formalin-fixed cells, tissue arrays, and sections were
antigen-retrieved and probed with anti-p63 (4A4) and anti-IKKα (sc-
7218) antibodies in combination with secondary antibodies conjugated
with Alexa Fluor 594 or 488 (Molecular Probes, Eugene, OR). Fluores-
cence image was acquired using a Radiance 2000 laser scanning confocal
microscope (Bio-Rad) with LaserSharp 2000 imaging software (Carl
Zeiss, Oberkochen, Germany) or fluorescence microscope (BZ-9000;
Keyence, Osaka, Japan).
Matrigel Invasion Assay
After rehydration, the Matrigel culture inserts (BD Biosciences,
San Jose, CA) were placed in the wells (24-well culture plates) contain-
ing the medium (0.5 ml) with 10% FBS. Cell suspension (5 × 104) in
0.5 ml of the medium with 0.1% bovine serum albumin was added to
the chamber and incubated for 18 hours.
Results
Lack of BMP Sensitivity in the TAp63 and ΔNp63
Promoter/Enhancer Regions
The TA and ΔN promoter/enhancer regions of 2 kbp (2kTA and
2kΔN, respectively) were linked 5′ to a firefly luciferase gene (luc)
(Figure 1A). We first tested 2kTA and 2kΔN for sensitivity to BMP2
in C2C12 cells (Figure W1A). Activation of these promoters by the
BMP-related Smad proteins was also assessed in HepG2 cells (Fig-
ure W1B). In comparison with the human Id1 promoter [33], neither
one showed a positive response in either experiment.
We next tested to see whether 2kTA and 2kΔN can be activated by
the canonical TGF-β signal by Smad2/3 paired with Smad4 in HepG2
cells (Figure W2A). Compared with the plasminogen activator in-
hibitor 1 (PAI-1) gene promoter [31], which was strongly activated
by Smad3 transfection and the following TGF-β1 stimulation (to
nearly 40-fold), 2kΔN showed a minimum detectable response to
Smad2 (an approximately 2- to 3-fold activation), without an obvious
response to TGF-β1. Smad4 was not a good partner of Smad2 in the
2kΔN activation.
Activation of the ΔNp63 Promoter by Smad2 and IKKα
We considered the possibility of 2kΔN activation by the newly
identified TGF-β signaling mechanism. A431 cells derived from an
epidermoid SCC persistently expressed endogenous p63 at a high level
[11]. In this cell line, the 2kΔN-driven luciferase expression was sig-
nificantly (20-fold) increased by Smad2 transfection (Figure 2A).
TGF-β1 (10 ng/ml) stimulation in the serum-starved (0.1% FBS)
medium further enhanced the effect of Smad2 (to ∼40-fold). Plasmid-
mediated IKKα expression elicited a minor response of 2kΔN (two-
fold). Combined transfection of Smad2 and IKKα (2:2), followed by
incubation with TGF-β1, also caused 2kΔNactivation by amagnitude
of ∼20. In contrast, no enhancement was detected by Smad3-only and
Smad4-only transfection or by the combination of Smad2-Smad4 or
Smad3-Smad4. Luciferase expression by 2kTA remained unchanged
(Figure 2C ). The PAI-1 promoter also responded to TGF-β1 (seven-
fold activation) when Smad3 was transfected (Figure 2D). In contrast to
the positive effects of Smad4 on PAI-1 in HepG2 cells (Figure W2A),
Smad4 failed to activate this promoter in A431 cells, and even elicited a
suppressive effect on Smad3.
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Within the 2kΔN region, we detected multiple SBE-related se-
quences referred to as SMD1 (starting at position −393), SMDHS-
1/2 (−248), and SMD2 (−204) (Figure 1A). A double-nucleotide
mutation was introduced to each site. The mutation of SMD2 (5′-
GTCTGTCT-3′) to SMD2m (5′-GTCgaTCT-3′) was sufficient to
cancel the activation of 2kΔN by Smad2 and IKKα, with or without
stimulation with TGF-β1 (Figure 2B). The SMD1m and SMD-
HS2m mutations did not affect the luc expression significantly. Thus,
SMD2 was determined as the common target site for Smad2 and
IKKα. Furthermore, this result ruled out the possibility that IKKα ac-
tivates 2kΔN through NF-κB because the Rel/NF-κB complex binds
to 5′-GGGRNNYYCC-3′ (R, purine; Y, pyrimidine).
Requirement of IKKα for Smad2-Induced 2kΔN Activation
We performed IKKα silencing followed by luciferase assay with
2kΔN-luc (Figure 3A). In comparison with the control Csi-introduced
A431 cells, luciferase activity produced by the IKKαsi-transfected cells
was decreased by approximately 50% on Smad2 cotransfection with or
without induction of TGF-β1. The levels of 2kΔN enhancement by
IKKα and the Smad2/IKKα combination declined likewise (∼50%).
Figure 2. Activation of the ΔNp63 promoter by Smad2 and IKKα, and by stimulation with TGF-β in A431 cells. Results of the luciferase assay
with 2kΔN (A), 2kΔNmutants (B), 2kTA (C) and thePAI-1 promoter (D) are shown. Cellswere incubatedwith (+) orwithout (−) TGF-β1 (TGF-b1)
(10 ng/ml [32]) for 24 hours after serum starvation for 6 hours. Data (mean ± SD; n ≥ 3) are presented as relative luciferase activities in
comparison with the control activity (1.0) produced by 2kΔN-luc transfected with empty expression vector pRcCMV (Vec). Statistic signifi-
cance: **P < .01, *P < .05, versus control experiment with Vec. Indicated in parentheses are amounts of the cytomegalovirus promoter–
driven gene expression vectors relative to 2kΔN-luc (=1). IKKa indicates IKKα.
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FaDu cells derived froma hypopharyngeal SCCdisplay an invasive phe-
notype [34–36], still expressing a level of p63 [8,15]. Without the entire
Smad4 gene [37,38], FaDu allowed activation of 2kΔN by Smad2 and
IKKα.When 10%FBSwas contained in the culturemedium throughout
the reporter assay, Smad2 caused an approximately five-fold increase in
the luciferase assay (Figure 3B, left), similar to the activation level in
A431 (seven-fold) under the same conditions (right).We detected a blunted
response of 2kΔN to both IKKα and Smad2 (∼70% reduction in the
luciferase activity) in IKKαsi-transfected FaDu cells (Figure 3B, middle).
Western blot analysis indicated a significant (55%-65%) decrease in
the IKKα protein 3 days after the IKKαsi transfection in the two cell
lines (Figure 3C ). Thus, endogenously expressed IKKα seemed essen-
tial for 2kΔN activation by transfected Smad2 in the reporter assay.
Endogenous ΔNp63 Induction by TGF-β in A431
To assess whether Smad2 is physically associated with the identified
sequences upstream of the ΔNp63-encoding sequences on chromo-
some 3, we performed ChIP experiments (Figure 4A). DNA fragments
coprecipitated with an anti-Smad2 antibody, anti-RNA polymerase II
antibody (anti–pol II), and a control nonimmune IgG were examined
for the SMD2 target sequence and the glutaraldehyde phosphate de-
hydrogenase (GAPDH) gene promoter sequence by PCR. A corre-
sponding segment in the TAp63 promoter/enhancer region was also
tested as a control. In A431 cells, the SMD2 site was more enriched
(four-fold or higher) in the anti-Smad2 precipitate than in the control
IgG precipitate, and the GAPDH promoter was more enriched in the
anti–pol II precipitate than in the control. The TA segment was not se-
lectively coprecipitated by any antibody examined. Thus, association of
Smad2 with the SMD2 site in A431 was strongly suggested.
In FaDu cells, however, the anti-Smad2 antibody failed to precipi-
tate the segment containing SMD2. Results with the anti–pol II and
control IgG were comparable to those in A431. Binding of Smad2 to
the SMD2 site on the chromosomal DNA was less probable in FaDu.
We next examined whether TGF-β could influence the endogenous
p63 expression. Two hours after the TGF-β1 (10 ng/ml) stimulation of
Figure 3. Smad2 requires endogenously expressed IKKα for activation of the ΔNp63 promoter. (A) Luc reporter assay in A431 cells with
IKKα silencing. Twenty-four hours after the siRNA (Csi, IKKαsi) introduction, cells were seeded onto 24-well plates to perform the luciferase
assaywith 2kΔN-luc and expression vectors of the Smadproteins and IKKα. Cellswere incubatedwith (+) orwithout (−) TGF-β1 (TGF-b1) as
described in the legend to Figure 2. Luciferase activity 48 hours after the 2kΔN-luc transfection was determined. Relative luciferase activity
(RLA) is represented asmean±SD; n≥ 3). Statistic significance: **P< .01, *P< .05, versus control experimentwith Vec. (B) IKKα silencing
in FaDu cells. We determined luciferase activities produced by the Csi- and IKKαsi-transfected cells cultured with 10% FBS. Results with
A431 under the same conditions are also shown. (C)Western blot analysis of A431 and FaDu cells with IKKα silencing. Day 3 cells after the
transfection of Csi and IKKαsi were analyzed for IKKα (85 kDa) and β-actin (43 kDa). Relative amounts of IKKα were obtained by standard-
ization with β-actin for each cell line.
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serum-starved A431 cells, ΔNp63 messenger RNA (mRNA) was
increased two-fold, which was retained to 4 hours (Figure 4B; RT-
PCR). The TA-type mRNA was not altered. A 1.7-fold (1.7 ± 0.2)
increase in ΔNp63α, the most predominant p63 protein, was obvious
20 hours after the TGF-β1 input (Figure 4B; Western blot). p63 expres-
sion in FaDu cells was not affected by TGF-β1 as observed in RT-PCR
and Western blot analysis. Thus, TGF-β1 enhanced the chromosomal
ΔNp63 transcription in A431 but not in FaDu.
Detection of Smad2-IKKα Association in the Nucleus of A431
The status of Smad2 and IKKα in the two SCC lines was analyzed by
Western blot analysis (Figure 5A). Under the normal culture condition
of A431, Smad2 existed in the cytosol and nucleus at a ratio of 8:2,
showing nuclear localization of the phosphorylated form, P-Smad, re-
active with antibodies recognizing phosphorylation at Ser465/467 of
this protein (Figure 5A, right). In addition to a large amount of IKKα
(85 kDa) in the cytosol, a small population of this protein (∼14%) was
detected in the nucleus.When Flag-tagged Smad2 was introduced into
A431 by transfection, the cytoplasmic/nuclear distribution of the en-
tire Smad2 molecules did not change significantly (Figure 5A, left).
IKKα was efficiently coprecipitated with phosphorylated Flag-Smad2
from the nuclear extract by an anti-flag antibody. Although a large
amount of IKKα was contained in the cytosol, it was poorly copreci-
pitated with Flag-Smad2 from the cytosol fraction.
FaDu cells contained a lesser amount of Smad2, ∼45% in comparison
with A431, showing its cytosolic and nuclear distributions at a ratio of
10:1 (Figure 5A, far right). Furthermore, IKKα was also decreased by
∼50% in the total amount and hardly detectable in the nuclear fraction.
These differences between the two cell lines were confirmed by im-
munofluorescence analyses (Figure 5B). A431 contained Smad2 inside
the nucleus as well as in the cytosol, whereas FaDu had a decreased
amount of Smad2 showing a brighter signal outside the nucleus. A sig-
nificant decrease in IKKα and the lack of the Smad4 protein in FaDu
were also observed.
Induction of an Invasion Activity Either by p63
or by IKKα Silencing
A431 cells displayed intense p63 immunofluorescence confined to
the nucleus as observed by laser scanning microscopy (Figure 6A, left).
Consistent with the Western blot analysis (Figure 5A), cells showing a
stronger IKKα label in the cytosol than in the nucleus were seen pre-
dominantly. Nuclear accumulation of IKKα was rarely detected (≤5%
cells). We carried out gene silencing by transfection of p63si and IKKαsi.
As reported other studies [18,28,29], p63 knockdown cells showed a
substantial decrease in IKKα. Conversely, IKKα knockdown cells also
displayed an obvious decrease in p63. This result not only supported
our results that IKKα facilitated p63 expression but also implied mu-
tual activation between p63 and IKKα in A431.
FaDu cells also showed a reduction of IKKα on the elimination of
p63 (Figure 6A, right). However, IKKα knockdown cells maintained
the p63 level as in the control Csi-transfected cells. In Western blot
analysis, all of the detectable p63 isoforms including ΔNp63α and
TAp63γ were greatly decreased by p63si transfection (Figure 6C , left),
Figure 4. Endogenous ΔNp63 activation by TGF-β1 in A431. (A) ChIP. A431 and FaDu nuclear extracts were examined for association of
Smad2 with the SMD2 site. Antibodies used and amplified chromosomal segments, SMD2 (220 bp), TA (282 bp), and GAPDH (166 bp) are
indicated. (B) Induction of endogenous ΔNp63 by TGF-β1. Cells incubated with TGF-β1 (10 ng/ml) for indicated periods (h) were analyzed
for TAp63 and ΔNp63 mRNA by RT-PCR. Total RNA from HEK293 was tested as a negative control of ΔNp63 expression. Ribosomal RNA
(18S) was amplified as a quantitative control. A 100-bpDNA ladderwas loaded in laneM. Cells incubatedwith (+) or without (−) TGF-β1 (for
20 hours) were also analyzed byWestern blot analysis for ΔNp63α. The blots were reprobed with an anti–β-actin antibody. Sizes (kDa) and
positions of the standard proteins are indicated.
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Figure 5. Status of the signalingmolecules in A431 and FaDu. (A) Smad2 and IKKαwere analyzed for the level of expression and subcellular
localization by Western blot analysis. (Left panels) Cytosolic (Cyt) and nuclear (Nuc) fractions were obtained from A431 cells transfected
with the Flag-Smad2 expression vector. Immunoprecipitation (IP) was carried out with a rabbit (R) anti-Flag antibody (PM020). Blot mem-
brane was probed with anti-Smad2 (sc-101153), anti-IKKα (sc-7218), anti-p84 nuclear protein (ab487), and anti-HSP90 (ab1429) antibodies.
Sizes (in kDa) and positions of the biotinylated standard proteins (Bm) and prestained colormarker proteins (Cm) are indicated. Positions of
Smad2 and phosphorylated Smad2 (P-Smad2) reactive with an anti–phospho-Smad2 (Ser465/467) antibody (#3101) are also indicated.
Ratios of the sample amounts analyzed are indicated in parentheses. Graphs show relative amounts of Smad2 and IKKα in the fractions
as determined bymeasurement of the band intensities (n= 3). (Right panels) Cytosol (Cyt) and nuclear (Nuc) fractions from untransfected
A431 and FaDu cells were examined. Protein band intensities were measured and standardized with HSP90 and the ratio of sample
amounts (1:6). Graphs show comparison of the total amount and subcellular distribution of Smad2 and IKKα between A431 and FaDu
(n = 3). (B) Immunofluorescence analysis of formalin-fixed A431 and FaDu cells. Scale bars, 50 μm.
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which was accompanied by an obvious reduction of IKKα. However,
IKKα silencing did not affect the p63 isoforms (Figure 6C , right). Given
the lack of Smad2-SMD2 association (Figure 4A) and the absence of
IKKα in the nucleus (Figure 5), the endogenous ΔNp63 expression
in FaDu cells may not depend on the Smad2-IKKα pathway of TGF-β.
In an invasion assay with Matrigel-coated membrane, FaDu cells
penetrated through the matrix protein complex, whereas A431 failed
to do so (Figure 6B). Interestingly, either by p63 or by IKKα gene si-
lencing, A431 gained an invasive activity, implying that both IKKα
and p63 are involved in the maintenance of the noninvasive phenotype
of A431 cells.
Changes in p63 and IKKα in the Progression of SCC
To assess alterations of p63 and IKKα during the SCC progression,
we analyzed conventional oral carcinoma sections at different stages,
hyperplasia (carcinoma in situ), well-differentiated (grade 1), and poorly
differentiated (grade 3), for p63 and IKKα by immunostaining (Fig-
ure 7A). Four or six cases of each grade were examined. Normal gingival
sections displayed nuclear p63 expression in the basal and suprabasal
layers of the epithelium as described [3,4]. The IKKα label was spread
throughout the cells, causing an enhanced signal in the cytoplasm. Hy-
perplasia lesions (4/4) displayed more enhanced p63 immunofluores-
cence than in the normal tissues. As observed in A431 (Figure 5), a
Figure 6. Induction of an invasion activity by p63 and IKKα knockdown in A431 cells. (A) Immunofluorescence analyses of siRNA-introduced
A431 and FaDu cells. Two days after transfectionwith Csi, p63si, and IKKαsi, cellswere formalin-fixed for immunostaining. Scale bars, 50 μm.
(B) Invasion assaywas carried out withMatrigel matrix cell culture inserts. A431 and FaDu cells without transfection (left) and A431 cells after
siRNA (Csi, p63si, and IKKαsi) transfection (right) were examined. Statistic significance: **P < .01 versus A431 (left), **P < .01 versus Csi
(right). (C) Western blot analysis for p63 and IKKα in FaDu cells transfected with siRNA. Positions of the p63 isoforms were determined as
described [15,47]. IKKα, β-actin, and sizes of the standard proteins are also shown.
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majority of the IKKα molecules existed in the cytoplasm. Intriguingly,
well-differentiated SCC lesions (6/6) displayed a significant enhance-
ment of p63 as well as nuclear accumulation of IKKα. Furthermore,
in poorly differentiated, invasive SCC sections (5/6), loss of p63 positive
cells, and relocalization of IKKα to the cytoplasm were profound.
To study more quantitatively the status of these proteins in SCCs, we
analyzed SCC tissue arrays. The BC34011 slide contained 60 cores of dif-
ferent stages (grades 1-3) of SCC and 3 cores of normal tissues. Six cores of
hyperplasia on OR802 were also examined. All of the tissue array immu-
nofluorescence images are presented in FiguresW3 andW4. Cells (100 <
n ≤ 350) in a typical field of view were sorted by 1) the presence (+) or
absence (−) of p63 and 2) nuclear accumulation (N > C) or cytoplasmic/
whole-cell distribution (N≤C) of IKKα.We obtained, for each core, com-
position (%) of the four categories: p63(+)/IKKα (N > C), p63(+)/IKKα
(N ≤ C), p63(−)/IKKα (N > C), and p63(−)/IKKα (N ≤C) (Figure 7B).
In normal gingiva and hyperplasia tissues, a large population (≥90%)
showed the p63(+)/IKKα (N ≤ C) phenotype in six of eight cores.
Interestingly, p63(+)/IKKα (N > C) cells were predominant (>50%)
Figure 7. Amplification of p63 with IKKα in well-differentiated SCC. (A) Oral carcinoma sections at different pathologic stages were analyzed
by immunofluorescence staining for p63 and IKKα. Typical images representing four or six individual samples of the indicated stages are
presented. The well-differentiated SCC images contain nests of keratin pearls in the dark areas. Scale bars, 50 μm. (B) Summary of the SCC
tissue array analysis. Composition (%) of the p63(+)/IKKα (N > C), p63(+)/IKKα (N≤ C), p63(−)/IKKα (N > C), and p63(−)/IKKα (N≤ C) popula-
tionswas calculated for each corewith predetermined cancer grade. Results are collectively shown for each category: normal, SCC grade 1, 2, 3
(indicated as I, II, III in array BC34011), and hyperplasia (OR802). ND* indicates not determined. (OR802-F8 and BC34011-G1 contained less
than 10 labeled cells in each field of view. BC34011-C9 showed cells with cytoplasmically localized p63 and was therefore eliminated.)
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in 9 of 12 cores of grade 1 SCC. Furthermore, the p63(+)/IKKα (N > C)
population was diminished markedly in grade 2 (moderately well differ-
entiated) tissues with a concomitant increase in the p63(−)/IKKα (N ≤C)
population. In grade 3 SCCs, p63(−)/IKKα (N ≤ C) cells were predom-
inant (>50%) in 22 of 25 cores. Only a small number (≤10%) of p63(+)/
IKKα (N > C) cells remained in 16 cores of grade 3.
These results suggest that the maximum expression of p63 at the
stage of well-differentiated SCC is associated with IKKα nuclear ac-
cumulation. Furthermore, the loss of p63 during the malignant con-
version seemed to occur concurrently with the decline of IKKα.
Discussion
We have shown that the ΔNp63 promoter is activated by the recently
identified keratinocyte-specific TGF-β signal pathway with Smad2
and IKKα in SCC. This mechanism may underlie the suppression
of malignant conversion by p63 and IKKα.
The SMD2 (5′-GTCTGTCT-3′) site matching the SBE consensus
was determined as the cis-acting sequence to respond to the Smad2/
IKKα signal. The zebrafish ΔNp63 promoter also contains SBE-like
sequences, with which epithelial cells responded to BMP2 in situ [20].
Our results do not necessarily dismiss the possibility that the human
BMP signaling also contributes to p63 expression in other cell types.
However, the functional SBE-like sequences in the ΔNp63 promoter
are little conserved between human and zebrafish (Figure 1), implying
that the disparity reflects diversification of the cis-regulatory sequences
and the transcription factor usage in mammalian evolution.
By the ChIP, TGF-β1 stimulation and gene silencing experiments,
we concluded that transcription of chromosomal ΔNp63 is activated
by the Smad2/IKKα signaling in A431 cells. In contrast, the pathway
seemed dispensable for ΔNp63 in FaDu cells, despite the observation
of 2kΔN transactivation by Smad2 in an IKKα-dependent mode. This
is not a contradiction between the assay results. Transfection of Smad2
in the reporter assay may have caused the pathway activation in FaDu.
Furthermore, transcription of ΔNp63 on the chromosomal DNA can
be influenced by the sequences upstream and downstream of the
2kΔN region and by proteins interacting with them.
Conversely, recent studies showed transcriptional activation of the
IKKα gene by p63 [18,28,29], the reverse reaction of our finding,
hypothesizing mutual activation between p63 and IKKα. This hy-
pothesis seems relevant to A431 cells in which IKKα knockdown
decreased p63 and vice versa. The same level of invasion activity
was induced by p63 and IKKα silencing in A431, implying that
the mutual activation mechanism is important to maintain the non-
invasive phenotype.
As many other SCC lines, A431 expresses both keratinocyte stem
cell markers and an early differentiation marker, involucrin [39].
When the IKKα distribution pattern and the result of invasion assay
are taken into account, we consider A431 to be an “advanced” hy-
perplasia. FaDu cells produce proinvasive molecules including furin,
matrix metalloproteinase 3 (MMP-3, also termed stromelysin-1), and
other MMPs, and characterized as an invasive SCC line [34,36],
which was consistent with our invasion assay. Earlier studies showed
that cell lines derived from SCCs all fail, to a greater or lesser extent,
to complete the process of keratinization [40,41], indicating a limi-
tation in well-differentiated SCC isolation as a cell line.
By an extensive histologic study in conjunction with biochemical
analyses, nuclear translocation of IKKα was found essential for the
keratinocyte-specific TGF-β pathway activation and for suppression
of the malignant conversion of SCC [23,27]. Our immunofluores-
cence analyses with tissue arrays are consistent with the previous studies
as well as our finding that IKKα acts in the p63-inducing mechanism.
The down-regulation of p63 during the malignant conversion
[10,11,13] may be associated with the significant decrease of IKKα
as demonstrated by the gene silencing and invasion assay with A431
(Figure 6).
Invasion and metastasis of SCC involve “epithelial-to-mesenchymal
transition” controlled by varied intracellular signaling pathways [42],
production of proteases [43], and functional interactions with fibro-
blasts [44] and endothelial cells [45]. The p63 and Smad2/IKKα sys-
tems independently control many target genes in keratinocytes
[14,16–19,23,27,46], which may collectively facilitate the proposed
invasion-suppressing function of the keratinocyte-specific TGF-β
signaling pathway. Mechanisms of the nuclear accumulation of IKKα
and its elimination in the course of SCC progression await exten-
sive studies.
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Figure W1. The p63 promoters do not respond to the BMP signal in C2C12 and HepG2 cells. (A) The TAp63 (2kTA), ΔNp63 (2kΔN), and
control Id1 (J Cell Physiol 2002;193:299–318) promoters were tested for ability to respond to BMP2 by luciferase gene (luc) expression
assay in C2C12 cells. After transfection of the Smad expression vector(s) with the luc plasmid at a ratio of 4:1, cells were incubatedwith (+)
or without (−) BMP2. Luciferase activity is indicated in relation to the enzyme expression (1.0) driven by the luc plasmid with the empty
vector (Vec) in the absence of BMP2. Data are represented as mean ± SEM. (B) The same promoters were examined for activation by
Smad-1, -4, and -5 in HepG2 cells without BMP2 induction.
Figure W2.Moderate activation of theΔNp63promoter bySmad2 and IKKα inHepG2cells. (A) The 2kTA, 2kΔNandPAI-1 promoter/enhancer
regionswere tested for sensitivity to Smad-2, -3, and -4 inHepG2 cells. After transfection of the Smadexpression vector(s) and the luc plasmid
at a ratio of 4:1, cells were serum-starved, and incubated with (+) or without (−) TGF-β1 (TGF-b1) for 24 hours. Relative luciferase activity is
shown. Data are represented as mean ± SEM. (B) 2kΔN and its mutants were analyzed for response to Smad2, Smad3, and IKKα (IKKa).
Figure W3. Immunofluorescence analysis of SCC tissue array BC34011. Immunofluorescence images of p63 (red) and IKKa (green) were
obtained for every core placed at rows A to G and columns 1 to 9. Predetermined cancer grades (1, 2, and 3) are denoted by I, II, and III.
Figure W3. (continued).
Figure W4. Immunofluorescence analysis of SCC tissue array OR802. Cores of hyperplasia (in row F, columns 5-10) are shown. Because
F8 contained less than 10 countable cells with a ductal cell morphology, this core was omitted from the analysis shown in Figure 7B.
